• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受芳香化酶抑制剂治疗的乳腺癌幸存者的阴道微生物组,伴有或不伴有外阴阴道症状。

Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms.

机构信息

Department of Obstetrics & Gynaecology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270, Rama VI Rd., Bangkok, 10400, Thailand.

Ramathibodi Medical School, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 111, Suwannabhumi Canal Rd., Samut Prakan, 10540, Thailand.

出版信息

Sci Rep. 2024 Mar 28;14(1):7417. doi: 10.1038/s41598-024-58118-3.

DOI:10.1038/s41598-024-58118-3
PMID:38548910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10978846/
Abstract

Genitourinary syndrome of menopause (GSM) is the leading cause of vaginal symptoms in breast cancer survivors treated with aromatase inhibitors. However, there are currently no effective treatment options available for women with a history of breast cancer. Recent research has established that changes in the vaginal microbiome may be linked to GSM. Most studies have assessed the microbiome without accounting for the estrogen status. It remains unknown whether the vaginal microbiome differ among patients with a low estrogenic state with and without vulvovaginal symptoms. To address such research questions, our study compares the vaginal microbiomes among breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms. A total of 50 breast cancer survivors treated with aromatase inhibitors were recruited, among whom 25 had vulvovaginal symptoms and 25 had no vulvovaginal symptoms. Vaginal swabs were collected. DNA extraction, followed by sequencing of the V3-V4 regions of the 16S ribosomal RNA gene, were performed. Differential abundance analysis was conducted by linear discriminant analysis effect size. Taxonomy assignment, alpha diversity and beta diversity were examined. The relative abundance of genus Sneathia and genus Gardnerella was significantly increased in vulvovaginal symptoms group with no differences in bacterial diversity and richness.

摘要

绝经后泌尿生殖系统综合征(GSM)是接受芳香化酶抑制剂治疗的乳腺癌幸存者阴道症状的主要原因。然而,目前对于有乳腺癌病史的女性,尚无有效的治疗选择。最近的研究已经确定,阴道微生物组的变化可能与 GSM 有关。大多数研究在评估微生物组时都没有考虑雌激素状态。在雌激素水平低且伴有或不伴有外阴阴道症状的患者中,阴道微生物组是否存在差异仍不清楚。为了解决这些研究问题,我们的研究比较了接受芳香化酶抑制剂治疗的乳腺癌幸存者中伴有和不伴有外阴阴道症状的阴道微生物组。共招募了 50 名接受芳香化酶抑制剂治疗的乳腺癌幸存者,其中 25 名有外阴阴道症状,25 名无外阴阴道症状。采集阴道拭子。进行 DNA 提取,然后对 16S 核糖体 RNA 基因的 V3-V4 区进行测序。通过线性判别分析效应大小进行差异丰度分析。检查了分类学分配、alpha 多样性和 beta 多样性。在外阴阴道症状组中,属 Sneathia 和属 Gardnerella 的相对丰度显著增加,而细菌多样性和丰富度无差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5787/10978846/b042987bab37/41598_2024_58118_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5787/10978846/b3d38b04d74f/41598_2024_58118_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5787/10978846/671e3c0b94a0/41598_2024_58118_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5787/10978846/b042987bab37/41598_2024_58118_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5787/10978846/b3d38b04d74f/41598_2024_58118_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5787/10978846/671e3c0b94a0/41598_2024_58118_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5787/10978846/b042987bab37/41598_2024_58118_Fig3_HTML.jpg

相似文献

1
Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms.接受芳香化酶抑制剂治疗的乳腺癌幸存者的阴道微生物组,伴有或不伴有外阴阴道症状。
Sci Rep. 2024 Mar 28;14(1):7417. doi: 10.1038/s41598-024-58118-3.
2
Assessing vaginal wall thickness by transvaginal ultrasound in breast cancer survivors: A pilot study.经阴道超声评估乳腺癌幸存者的阴道壁厚度:一项初步研究。
Maturitas. 2023 May;171:7-12. doi: 10.1016/j.maturitas.2023.02.001. Epub 2023 Feb 24.
3
Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.二氧化碳点阵激光与假激光治疗激素治疗相关绝经后女性生殖泌尿综合征接受芳香化酶抑制剂治疗的乳腺癌幸存者性功能障碍的效果:LIGHT 随机临床试验。
JAMA Netw Open. 2023 Feb 1;6(2):e2255697. doi: 10.1001/jamanetworkopen.2022.55697.
4
Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study.接受芳香化酶抑制剂治疗的乳腺癌幸存者中普拉睾酮的安全性:VIBRA 初步研究。
Climacteric. 2022 Oct;25(5):476-482. doi: 10.1080/13697137.2022.2050208. Epub 2022 Mar 28.
5
Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy.管理接受内分泌治疗的乳腺癌幸存者的泌尿生殖系统绝经综合征。
J Oncol Pract. 2019 Jul;15(7):363-370. doi: 10.1200/JOP.18.00710.
6
Missing documentation in breast cancer survivors: genitourinary syndrome of menopause.乳腺癌幸存者的缺失文档:绝经后生殖泌尿系统综合征。
Menopause. 2017 Dec;24(12):1360-1364. doi: 10.1097/GME.0000000000000926.
7
Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review.阴道激光治疗乳腺癌幸存者女性泌尿生殖系统绝经综合征的新用途:综述。
Medicina (Kaunas). 2023 Jan 9;59(1):132. doi: 10.3390/medicina59010132.
8
Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis.乳腺癌幸存者外阴阴道萎缩激素治疗的安全性及血清雌二醇水平:一项系统评价与荟萃分析
Clin Breast Cancer. 2023 Dec;23(8):835-846. doi: 10.1016/j.clbc.2023.08.003. Epub 2023 Aug 22.
9
Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies.治疗乳腺癌幸存者的泌尿生殖系统绝经综合征:主要挑战和有前途的策略。
Climacteric. 2023 Aug;26(4):296-301. doi: 10.1080/13697137.2023.2184253. Epub 2023 Mar 22.
10
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?乳腺癌幸存者的绝经后泌尿生殖综合征:我们是否迎来了新的安全希望?
Clin Breast Cancer. 2015 Dec;15(6):413-20. doi: 10.1016/j.clbc.2015.06.005. Epub 2015 Jun 18.

引用本文的文献

1
Microbial Signatures in Breast Cancer: Exploring New Potentials Across Body Niches.乳腺癌中的微生物特征:探索全身生态位的新潜力
Int J Mol Sci. 2025 Sep 5;26(17):8654. doi: 10.3390/ijms26178654.
2
Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management.芳香化酶抑制剂在早期乳腺癌辅助治疗中的应用:对毒性及其管理的见解
Cancers (Basel). 2025 Aug 22;17(17):2726. doi: 10.3390/cancers17172726.

本文引用的文献

1
The urinary, vaginal and gut microbiota in women with genital lichen sclerosus - A case-control study.患有外阴硬化性苔藓的女性的泌尿生殖道和肠道微生物群:一项病例对照研究。
Eur J Obstet Gynecol Reprod Biol. 2023 Oct;289:1-8. doi: 10.1016/j.ejogrb.2023.08.004. Epub 2023 Aug 8.
2
Battle royale: Immune response on biofilms - host-pathogen interactions.激烈竞争:生物膜上的免疫反应——宿主与病原体的相互作用
Curr Res Immunol. 2023 Mar 28;4:100057. doi: 10.1016/j.crimmu.2023.100057. eCollection 2023.
3
Editorial: Vaginal dysbiosis and biofilms.
社论:阴道生态失调与生物膜
Front Cell Infect Microbiol. 2022 Aug 9;12:976057. doi: 10.3389/fcimb.2022.976057. eCollection 2022.
4
Lactobacilli displacement and Candida albicans inhibition on initial adhesion assays: a probiotic analysis.初始黏附试验中乳酸菌的取代和白色念珠菌的抑制:益生菌分析。
BMC Res Notes. 2022 Jul 7;15(1):239. doi: 10.1186/s13104-022-06114-z.
5
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.《NCCN 肿瘤学临床实践指南:乳腺癌》第 3.2022 版
J Natl Compr Canc Netw. 2022 Jun;20(6):691-722. doi: 10.6004/jnccn.2022.0030.
6
Clustering Analysis of the Multi-Microbial Consortium by Species Against Vaginal Dysbiosis Among Ecuadorian Women.基于物种的多微生物联合体对厄瓜多尔妇女阴道失调的聚类分析。
Front Cell Infect Microbiol. 2022 May 11;12:863208. doi: 10.3389/fcimb.2022.863208. eCollection 2022.
7
Vaginal microbiome of women with adenomyosis: A case-control study.腺肌病患者的阴道微生物组:一项病例对照研究。
PLoS One. 2022 Feb 16;17(2):e0263283. doi: 10.1371/journal.pone.0263283. eCollection 2022.
8
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
9
Vaginal Microbiota of the Sexually Transmitted Infections Caused by and in Women with Vaginitis in Taiwan.台湾阴道炎女性中由[具体病原体1]和[具体病原体2]引起的性传播感染的阴道微生物群
Microorganisms. 2021 Sep 2;9(9):1864. doi: 10.3390/microorganisms9091864.
10
Comparative Effectiveness of Treatments for Bacterial Vaginosis: A Network Meta-Analysis.细菌性阴道病治疗方法的比较效果:一项网状荟萃分析。
Antibiotics (Basel). 2021 Aug 13;10(8):978. doi: 10.3390/antibiotics10080978.